Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.